Research and Development Business Capabilities Model

A detailed, multi-level capability map for the Research and Development sector, covering 200+ business capabilities organized across three hierarchical levels. R&D looks completely different on the surface at a pharmaceutical company, a chipmaker, and an industrial manufacturer, but idea management, stage-gate development, and IP protection are the same underlying capabilities in all three — this model is built at that level, not any single industry's version of it.

Why a capability model, not a prompt

A generic AI prompt for "R&D capabilities" tends to fail in one of two specific ways. Either it stays so generic — "research," "development," "testing" — that it's useless as a planning tool, or it unconsciously imports one industry's R&D process and presents it as universal: ask with any pharma context nearby and you'll often get a clinical-trial-phase structure (preclinical, Phase I-III, regulatory submission) that has nothing to do with a chipmaker's silicon design cycle or a consumer-goods company's formulation and testing process. What's actually industry-neutral sits one level up from the science: idea and portfolio management (capturing, scoring, and funding R&D bets), stage-gate development (moving a concept through defined go/no-go decision points), technology scouting and IP protection (finding external innovation and defending what you build), and R&D resource and budget allocation. Those capabilities are structurally identical whether the output is a drug, a chip, or a jet engine, even though the underlying science and gate criteria differ completely. This model is built at that industry-neutral layer on purpose, so a technology company and a pharmaceutical company can plan against the same capability structure without either one importing the other's process by accident.

What's Inside

• Capability Map — 200+ capabilities across Level 1 (strategic), Level 2 (tactical), and Level 3 (operational), in PowerPoint, Word, and Excel
• Capability Definitions — Clear descriptions at the most granular level for consistent interpretation
• Capability KPIs — Measurable indicators at Level 2 to assess maturity and performance

How Teams Use It

• Baseline idea-to-launch portfolio and stage-gate maturity before an R&D operating-model redesign or portfolio-management (PPM) platform selection
• Scope an innovation-management or R&D PPM RFP against actual portfolio and gate capabilities instead of a vendor's feature list
• Give R&D, legal/IP, and corporate strategy a shared vocabulary for technology scouting, in-licensing, and IP protection decisions
• Apply one consistent capability structure across business units or acquired companies that span different industries and different R&D processes

Who It's For

R&D and innovation leaders, chief technology officers, portfolio and stage-gate program managers, IP and technology-transfer teams, and enterprise architects standardizing R&D capability models across business units or industries.